- Home
- / Kiwa Bio-Tech
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Kiwa Bio-Tech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2023-09-25
Market Capitalization
$56.5 K
2023-09-25
Revenue
$40.1 M
FY, 2019
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.6M | 17.3M | 30.7M | 40.1M | |||||
| Cost of goods sold | 7.2M | 11.8M | 22.4M | 30.8M | |||||
| Gross profit | 2.4M | 5.4M | 8.3M | 9.3M | |||||
| Gross profit margin, % | 25.2% | 31.4% | 26.9% | 23.3% | |||||
| General and administrative expense | 1.3M | 1.0M | 394.1K | 364.8K | 313.6K | 868.8K | 3.0M | 4.9M | 4.4M |
| Operating expense total | 1.4M | 1.2M | 556.9K | 527.6K | 492.6K | 1.5M | 3.6M | 5.7M | 10.5M |
| EBIT | (1.4M) | (1.2M) | (556.9K) | (527.6K) | (492.6K) | 872.7K | 1.8M | 2.6M | (1.2M) |
| EBIT margin, % | 9.1% | 10.4% | 8.4% | -3.0% | |||||
| Interest expense | 268.5K | 253.2K | 187.7K | 184.8K | 593.7K | 120.9K | 339.3K | ||
| Pre tax profit | (268.5K) | (1.5M) | 3.7M | (617.6K) | (677.4K) | 1.5M | 1.9M | 2.3M | (5.0M) |
| Income tax expense | 424.9K | (1.1M) | (1.9M) | (1.7M) | |||||
| Net Income | (1.7M) | (1.3M) | 3.7M | (617.6K) | (677.4K) | 891.0K | 5.3M | 343.8K | (6.6M) |